UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder

British journal of cancer, 2013-09, Vol.109 (6), p.1460-1466

2013

Volltextzugriff (PDF)

Considerations for successful cancer immunotherapy in aged hosts

Clinical and experimental immunology, 2017-01, Vol.187 (1), p.53-63

2017

Volltextzugriff (PDF)

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling

British journal of cancer, 2012-11, Vol.107 (11), p.1826-1832

2012

Volltextzugriff (PDF)

Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: results from a privately insured patient population

Prostate cancer and prostatic diseases, 2015-03, Vol.18 (1), p.13-17

2015

Volltextzugriff (PDF)

P203 - Utilization of palliative care in bladder cancer: Delineating patterns of care and associated disparities

European urology, 2024-03, Vol.85, p.S282-S282

2024

Volltextzugriff (PDF)

Utilization of palliative care in bladder cancer: Delineating patterns of care and associated disparities

European urology, 2024-03, Vol.85, p.S282

2024

Volltextzugriff (PDF)

Radical cystectomy vs systemic therapy in non-metastatic bladder cancer with advanced lymph nodal disease (cN2/N3 disease) using inverse probability weighting analysis

European urology, 2022-02, Vol.81, p.S1152-S1153

2022

Volltextzugriff (PDF)

A0862 - Urine analysis: A convenient and strong indicator for renal function assessment in surgery for renal cancer

European urology, 2023-02, Vol.83, p.S1220-S1221

2023

Volltextzugriff (PDF)

A0553 - Impact of systemic treatments on overall survival in metastatic urothelial bladder cancer: A time-trend analysis

European urology, 2023-02, Vol.83, p.S791-S792

2023

Volltextzugriff (PDF)

Urine analysis: A convenient and strong indicator for renal function assessment in surgery for renal cancer

European urology, 2023-02, Vol.83, p.S1220-S1221

2023

Volltextzugriff (PDF)

Comparison of contemporary treatment strategies for locally advanced (stage IIIB) urothelial bladder cancer using National Cancer Database

European urology, 2023-02, Vol.83, p.S1895-S1896

2023

Volltextzugriff (PDF)

Impact of systemic treatments on overall survival in metastatic urothelial bladder cancer: A time-trend analysis

European urology, 2023-02, Vol.83, p.S791-S792

2023

Volltextzugriff (PDF)

A1302 - Comparison of contemporary treatment strategies for locally advanced (stage IIIB) urothelial bladder cancer using National Cancer Database

European urology, 2023-02, Vol.83, p.S1895-S1896

2023

Volltextzugriff (PDF)

A0157 - Molecular subtyping for predicting non-organ confined disease and survival outcomes after radical cystectomy in clinical high-grade T1 and T2 bladder cancer patients

European urology, 2024-03, Vol.85, p.S892-S892

2024

Volltextzugriff (PDF)

Molecular subtyping for predicting non-organ confined disease and survival outcomes after radical cystectomy in clinical high-grade T1 and T2 bladder cancer patients

European urology, 2024-03, Vol.85, p.S892

2024

Volltextzugriff (PDF)

POD-05.04 Stage pT0 After Radical Cystectomy: Are All Patients Equal?

Urology (Ridgewood, N.J.), 2011, Vol.78 (3), p.S17-S17

2011

Volltextzugriff (PDF)

POD-05.05 Risk Stratification of Patients Who Are pT0N0 after Radical Cystectomy

Urology (Ridgewood, N.J.), 2011, Vol.78 (3), p.S17-S18

2011

Volltextzugriff (PDF)

Intraluminal crystalloids are highly associated with prostatic adenocarcinoma on concurrent biopsy specimens

Prostate cancer and prostatic diseases, 2007-09, Vol.10 (3), p.279-282

2007

Volltextzugriff (PDF)

Should we screen for bladder cancer in a high-risk population? : A cost per life-year saved analysis

Cancer, 2006-09, Vol.107 (5), p.982-990

2006

Volltextzugriff (PDF)

Pre-Treatment Nomogram for Disease-Specific Survival of Patients with Chemotherapy-Naive Androgen Independent Prostate Cancer

European urology, 2006-04, Vol.49 (4), p.666-674

2006

Volltextzugriff (PDF)

Critical analysis of prostate‐specific antigen doubling time calculation methodology

Cancer, 2006-03, Vol.106 (5), p.1047-1053

2006

Volltextzugriff (PDF)

Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer

Italian journal of urology and nephrology, 2008-12, Vol.60 (4), p.217

2008

Volltextzugriff (PDF)

Prognostic factors of cancer recurrence and progression in non-muscle-invasive urothelial carcinoma: A multicenter study of over 4,300 patients

Journal of clinical oncology, 2011-03, Vol.29 (7_suppl), p.249-249

2011

Volltextzugriff (PDF)

Use of P63 expression to define a lethal subset of muscle-invasive bladder cancers

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4653-4653

2011

Volltextzugriff (PDF)

Correlation of disease-free survival at 2 to 3 years and 5-year overall survival in patients with muscle-invasive bladder cancer undergoing radical cystectomy

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4576-4576

2010

Volltextzugriff (PDF)

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(129)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(74)
Life Sciences & Biomedicine
(47)
Humans
(38)
Male
(24)
Urology & Nephrology
(22)
Female
(21)
Technology
(20)
Urology
(19)
Aged
(18)
Oncology
(18)
Biological And Medical Sciences
(17)
Middle Aged
(17)
Bladder Cancer
(15)
Medical Sciences
(15)
Nephrology. Urinary Tract Diseases
(13)
Physical Sciences
(12)
Science & Technology - Other Topics
(11)
Animals
(10)
Computer Science
(10)
Tumors
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder

Considerations for successful cancer immunotherapy in aged hosts

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling

Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: results from a privately insured patient population

P203 - Utilization of palliative care in bladder cancer: Delineating patterns of care and associated disparities

Utilization of palliative care in bladder cancer: Delineating patterns of care and associated disparities

Radical cystectomy vs systemic therapy in non-metastatic bladder cancer with advanced lymph nodal disease (cN2/N3 disease) using inverse probability weighting analysis

A0862 - Urine analysis: A convenient and strong indicator for renal function assessment in surgery for renal cancer

A0553 - Impact of systemic treatments on overall survival in metastatic urothelial bladder cancer: A time-trend analysis

Urine analysis: A convenient and strong indicator for renal function assessment in surgery for renal cancer

Comparison of contemporary treatment strategies for locally advanced (stage IIIB) urothelial bladder cancer using National Cancer Database

Impact of systemic treatments on overall survival in metastatic urothelial bladder cancer: A time-trend analysis

A1302 - Comparison of contemporary treatment strategies for locally advanced (stage IIIB) urothelial bladder cancer using National Cancer Database

A0157 - Molecular subtyping for predicting non-organ confined disease and survival outcomes after radical cystectomy in clinical high-grade T1 and T2 bladder cancer patients

Molecular subtyping for predicting non-organ confined disease and survival outcomes after radical cystectomy in clinical high-grade T1 and T2 bladder cancer patients

POD-05.04 Stage pT0 After Radical Cystectomy: Are All Patients Equal?

POD-05.05 Risk Stratification of Patients Who Are pT0N0 after Radical Cystectomy

Intraluminal crystalloids are highly associated with prostatic adenocarcinoma on concurrent biopsy specimens

Should we screen for bladder cancer in a high-risk population? : A cost per life-year saved analysis

Pre-Treatment Nomogram for Disease-Specific Survival of Patients with Chemotherapy-Naive Androgen Independent Prostate Cancer

Critical analysis of prostate‐specific antigen doubling time calculation methodology

Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer

Prognostic factors of cancer recurrence and progression in non-muscle-invasive urothelial carcinoma: A multicenter study of over 4,300 patients

Use of P63 expression to define a lethal subset of muscle-invasive bladder cancers

Correlation of disease-free survival at 2 to 3 years and 5-year overall survival in patients with muscle-invasive bladder cancer undergoing radical cystectomy

Suchergebnisse filtern